Chargement en cours...
Vildagliptin reduces plasma stromal cell‐derived factor‐1α in patients with type 2 diabetes compared with glimepiride
AIMS/INTRODUCTION: Dipeptidyl peptidase‐4 inhibitors might have pleiotropic protective effects on cardiovascular disease (CVD), in contrast to sulfonylureas. Therefore, we compared various CVD risk factors between vildagliptin and glimepiride. MATERIALS AND METHODS: We carried out a randomized, pros...
Enregistré dans:
| Publié dans: | J Diabetes Investig |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5334315/ https://ncbi.nlm.nih.gov/pubmed/27575011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12572 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|